What is multiple sclerosis?

Multiple sclerosis is a chronic autoimmune disease that affects the central nervous system, causing communication problems between the brain and the rest of the body.

Which are the diagnostic tools used for detection of multiple sclerosis?

Diagnostic tools for multiple sclerosis include magnetic resonance imaging (MRI) to detect lesions in the central nervous system, cerebrospinal fluid analysis to check for abnormalities, and neurological examinations to assess symptoms and signs of the disease.

Which country leads the market of multiple sclerosis diagnosis and treatment?

North America leads the market for multiple sclerosis diagnosis and treatment.

What are the references?

National Institute of Health, Food and Drug Administration, World Health organization, ScienceDirect, HHS.gov., National Multiple Sclerosis Society.

Multiple Sclerosis Diagnosis and Treatment Market Top Companies

Content

Introduction Research Methodology Executive Summary Market Overview Global Multiple Sclerosis Diagnosis and Treatment Market Assessment North America Multiple Sclerosis Diagnosis and Treatment Market Assessment Europe Multiple Sclerosis Diagnosis and Treatment Market Assessment Asia Pacific Multiple Sclerosis Diagnosis and Treatment Market Assessment Middle East and Africa Multiple Sclerosis Diagnosis and Treatment Market Assessment South America Multiple Sclerosis Diagnosis and Treatment Market Assessment Company Profiles Conclusion & Recommendations

Introduction

Research Objective
Scope of the Study
Definition and Taxonomy

Research Methodology

Research Approach
Data Sources
Assumptions

Executive Summary

Synopsis
Analyst Recommendations

Market Overview

Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
Value Chain Analysis
- Raw Material Sourcing
- Manufacturing Process
- Logistics & Transportation
- Buyer Preferences
Trends
- Market Trends
- Technological Trends
Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitute
- Threat of New Entrants
- Degree of Competition
PESTLE Analysis for 5 Leading Countries
- Regulatory Framework for Leading Countries/Regions
- Supply Demand Analysis
- Production & Consumption Statistics
- Export Import Statistics
- Price Trend Analysis

Global Multiple Sclerosis Diagnosis and Treatment Market Assessment

Overview
Global Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
- Clinically Isolated Syndrome (CIS)
- Relapse-Remitting MS (RRMS)
- Primary Progressive MS (PPMS)
- Secondary Progressive MS (SPMS)
Global Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
- Imaging Tests
- Spinal Fluid Analysis
- Other Tests
Global Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
- Medications
  - Injectables
    - Beta Interferons
    - Glatiramer Acetate
  - Oral Medications
    - Fingolimod
    - Dimethyl Fumarate
    - Teriflunomide
    - Cladribine
    - Diroximel Fumarate
    - Siponimod Tablets
  - Infusion Treatments
    - Natalizumab
    - Ocrelizumab
    - Alemtuzumab
    - Mitoxantrone
- Physical, Occupational or Speech Therapy
- Mental Health Counselling
Global Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America

North America Multiple Sclerosis Diagnosis and Treatment Market Assessment

Overview
North America Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
- Clinically Isolated Syndrome (CIS)
- Relapse-Remitting MS (RRMS)
- Primary Progressive MS (PPMS)
- Secondary Progressive MS (SPMS)
North America Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
- Imaging Tests
- Spinal Fluid Analysis
- Other Tests
North America Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
- Medications
  - Injectables
    - Beta Interferons
    - Glatiramer Acetate
  - Oral Medications
    - Fingolimod
    - Dimethyl Fumarate
    - Teriflunomide
    - Cladribine
    - Diroximel Fumarate
    - Siponimod Tablets
  - Infusion Treatments
    - Natalizumab
    - Ocrelizumab
    - Alemtuzumab
    - Mitoxantrone
- Physical, Occupational or Speech Therapy
- Mental Health Counselling

Europe Multiple Sclerosis Diagnosis and Treatment Market Assessment

Overview
Europe Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
- Clinically Isolated Syndrome (CIS)
- Relapse-Remitting MS (RRMS)
- Primary Progressive MS (PPMS)
- Secondary Progressive MS (SPMS)
Europe Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
- Imaging Tests
- Spinal Fluid Analysis
- Other Tests
Europe Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
- Medications
  - Injectables
    - Beta Interferons
    - Glatiramer Acetate
  - Oral Medications
    - Fingolimod
    - Dimethyl Fumarate
    - Teriflunomide
    - Cladribine
    - Diroximel Fumarate
    - Siponimod Tablets
  - Infusion Treatments
    - Natalizumab
    - Ocrelizumab
    - Alemtuzumab
    - Mitoxantrone
- Physical, Occupational or Speech Therapy
- Mental Health Counselling

Asia Pacific Multiple Sclerosis Diagnosis and Treatment Market Assessment

Overview
Asia Pacific Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
- Clinically Isolated Syndrome (CIS)
- Relapse-Remitting MS (RRMS)
- Primary Progressive MS (PPMS)
- Secondary Progressive MS (SPMS)
Asia Pacific Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
- Imaging Tests
- Spinal Fluid Analysis
- Other Tests
Asia Pacific Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
- Medications
  - Injectables
    - Beta Interferons
    - Glatiramer Acetate
  - Oral Medications
    - Fingolimod
    - Dimethyl Fumarate
    - Teriflunomide
    - Cladribine
    - Diroximel Fumarate
    - Siponimod Tablets
  - Infusion Treatments
    - Natalizumab
    - Ocrelizumab
    - Alemtuzumab
    - Mitoxantrone
- Physical, Occupational or Speech Therapy
- Mental Health Counselling

Middle East and Africa Multiple Sclerosis Diagnosis and Treatment Market Assessment

Overview
Middle East and Africa Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
- Clinically Isolated Syndrome (CIS)
- Relapse-Remitting MS (RRMS)
- Primary Progressive MS (PPMS)
- Secondary Progressive MS (SPMS)
Middle East and Africa Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
- Imaging Tests
- Spinal Fluid Analysis
- Other Tests
Middle East and Africa Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
- Medications
  - Injectables
    - Beta Interferons
    - Glatiramer Acetate
  - Oral Medications
    - Fingolimod
    - Dimethyl Fumarate
    - Teriflunomide
    - Cladribine
    - Diroximel Fumarate
    - Siponimod Tablets
  - Infusion Treatments
    - Natalizumab
    - Ocrelizumab
    - Alemtuzumab
    - Mitoxantrone
- Physical, Occupational or Speech Therapy
- Mental Health Counselling

South America Multiple Sclerosis Diagnosis and Treatment Market Assessment

Overview
South America Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
- Clinically Isolated Syndrome (CIS)
- Relapse-Remitting MS (RRMS)
- Primary Progressive MS (PPMS)
- Secondary Progressive MS (SPMS)
South America Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
- Imaging Tests
- Spinal Fluid Analysis
- Other Tests
South America Multiple Sclerosis Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
- Medications
  - Injectables
    - Beta Interferons
    - Glatiramer Acetate
  - Oral Medications
    - Fingolimod
    - Dimethyl Fumarate
    - Teriflunomide
    - Cladribine
    - Diroximel Fumarate
    - Siponimod Tablets
  - Infusion Treatments
    - Natalizumab
    - Ocrelizumab
    - Alemtuzumab
    - Mitoxantrone
- Physical, Occupational or Speech Therapy
- Mental Health Counselling

Company Profiles

Siemens Healthineers AG
- Company Overview
- Geographic Footprints
- Financial Performance
- Product Portfolio
- SWOT Analysis
- R&D Efforts
- Recent Developments & Strategic Collaborations
  - Product Launch/M&A/Technical Collaboration
General Electric Company
F. Hoffmann-La Roche Ltd.
Biogen Inc.
Merck & Co., Inc.
Novartis AG
Sanofi S.A.
Bristol Myers Squibb Company
Teva Pharmaceutical Industries Ltd.
Abbott Laboratories

Conclusion & Recommendations

Insight Code: 5140
No. of Pages: 150+
Format: PDF/PPT/Excel
Published: May 2024
Report Covered: [Revenue + Volume]
Historical Year: 2021-2022
Base Year: 2023
Estimated Years: 2024-2033

Proceed To Buy

Global Deep Dive Analysis

USD 3800

Single Region (NA,EU,APAC,LA,MEA)

USD 2900

Databook

USD 1900

Cross-Sectional Analysis

USD 5500

We use cookies to improve your experience